tokens: BACKGROUND : Markers of fibrinolysis , thrombin - activatable fibrinolysis inhibitor ( TAFI ), tissue - type plasminogen activator ( tPA ), and plasminogen activator inhibitor - 1 ( PAI - 1 ) levels were studied for the evaluation of short - term effects of raloxifene administration in postmenopausal women .